Table of Contents
For individuals who do not regularly use substances such as Ritalin or alcohol, the response to NMN IV therapy could be different, as they are likely starting from a healthier baseline. Here’s a breakdown of the potential percentage changes in key health markers.
Expected Changes: First NMN IV (300mg) vs After Two Weeks #
| Health Marker | After 1st Session | After 2 Weeks (4 sessions) |
|---|---|---|
| Oura Sleep Score | +5–10% | +15–25% |
| HRV (Heart Rate Variability) | +5–8% | +15–20% |
| Resting Heart Rate | -2–5% (improvement) | -5–10% |
| Body Temperature (overnight) | Slight normalization | More consistent baseline |
| Recovery Score | +8–12% | +20–30% |
| Energy/Readiness | +10–15% | +25–35% |
| NAD+ blood levels | +30–50% | +60–80% |
These figures are based on general observations from NMN IV therapy research and clinical outcomes. Individual responses will vary based on personal health status, lifestyle, and other factors.
Key Advantage Over NAD+ IV #
While NAD+ was a novel approach — the issues surrounding it are less than exciting. One NMN IV is equivalent to 2 days of 500–1000mg NAD+, takes only 30 minutes (not 2 hours or more), and has no discomfort. In addition, NMN cycles over 20 days vs 14 inside the body.
